This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hattori, N. Articles by Ueda, M. Search for Related Content PubMed PubMed Citation Articles by Hattori, N. Articles by Ueda, M.

Epoxide Hydrolase Affects Estrogen Production in the Human Ovary*

Department of Gynecology and Obstetrics, Faculty of Medicine (N.H., H.F., S.F.), Institute for Frontier Medical Science (M.M.), and Institute for Virus Research (M.U.), Kyoto University, Sakyo-ku, Kyoto, 606-8507, Japan

To investigate the mechanisms of ovarian cell differentiation, we raised a new monoclonal antibody, HCL-3, which reacted with human luteal cells. It also reacted with human and porcine hepatocytes. The immunoaffinity-purified HCL-3 antigen from human corpora lutea (CL) was shown to be a 46-kDa protein. The N-terminal 22 amino acids of the 46-kDa protein from porcine liver exhibited high homology (82%) to human microsomal epoxide hydrolase (mEH). The purified HCL-3 antigen from human CL or porcine liver showed EH enzyme activity, confirming that HCL-3 antigen is identical to mEH, which is reported to detoxify the toxic substrates in the liver. In human follicles, mEH was immunohistochemically detected on granulosa and theca interna cells. In the menstrual and pregnant CL, mEH was also expressed on large and small luteal cells. A competitive inhibitor of EH, 1,2-epoxy-3,3,3-trichloropropane, inhibited the conversion of estradiol from testosterone by granulosa cells cultured in vitro, indicating the involvement of mEH in ovarian estrogen production. Because anticonvulsant sodium valproate and its analogues were reported to inhibit EH enzyme activity, these findings provide a new insight into the etiology of endocrine disorders that are frequently observed among epileptic patients taking anticonvulsant drugs.

This article has been cited by other articles:

				X. Yang, S.-H. Liang, D. M. Weyant, P. Lazarus, C. J. Gallagher, and C. J. Omiecinski The Expression of Human Microsomal Epoxide Hydrolase Is Predominantly Driven by a Genetically Polymorphic Far Upstream Promoter J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 23 - 30. [Abstract] [Full Text] [PDF]

				A. W.Y. Cheong, Y.-L. Lee, W.-M. Liu, W. S.B. Yeung, and K.-F. Lee Oviductal Microsomal Epoxide Hydrolase (EPHX1) Reduces Reactive Oxygen Species (ROS) Level and Enhances Preimplantation Mouse Embryo Development Biol Reprod, July 1, 2009; 81(1): 126 - 132. [Abstract] [Full Text] [PDF]

				K. S. Rajapaksa, I. G. Sipes, and P. B. Hoyer Involvement of Microsomal Epoxide Hydrolase Enzyme in Ovotoxicity Caused by 7,12-Dimethylbenz[a]anthracene Toxicol. Sci., April 1, 2007; 96(2): 327 - 334. [Abstract] [Full Text] [PDF]

				G. J. Tranah, E. Giovannucci, J. Ma, C. Fuchs, S. E. Hankinson, and D. J. Hunter Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study Carcinogenesis, July 1, 2004; 25(7): 1211 - 1218. [Abstract] [Full Text] [PDF]

				E. A. Cannady, C. A. Dyer, P. J. Christian, I. G. Sipes, and P. B. Hoyer Expression and Activity of Microsomal Epoxide Hydrolase in Follicles Isolated from Mouse Ovaries Toxicol. Sci., July 1, 2002; 68(1): 24 - 31. [Abstract] [Full Text] [PDF]